A Closer Look at 5 Analyst Recommendations For CareDx
Portfolio Pulse from Benzinga Insights
In the past three months, analysts have shown varied sentiments towards CareDx (NASDAQ:CDNA), with a majority being bullish. The average 12-month price target has increased significantly, indicating positive expectations. CareDx has shown strong financial performance with notable revenue growth and efficient cost management.
October 22, 2024 | 1:02 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
CareDx has received predominantly bullish analyst ratings, with a significant increase in the average 12-month price target. The company's strong financial performance, including a 31.26% revenue growth, supports this positive outlook.
The majority of analysts have given CareDx a bullish rating, with a significant increase in the average price target from $21.33 to $32.2. This reflects positive sentiment and expectations for the company's future performance. Additionally, CareDx's strong financial metrics, such as a 31.26% revenue growth, further bolster the positive outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100